Abstract
BackgroundTisotumab vedotin (TV) is an investigational antibody-drug conjugate composed of a tissue factor (TF)-directed human monoclonal antibody covalently linked to the microtubule-disrupting agent monomethyl auristatin E (MMAE) via a protease-cleavable...
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have